PRKN and Parkinson disease: In addition, in recent years, CRISPR/Cas9 genome editing technology has been gradually applied to study kinase-encoding genes involved in the pathogenesis of PD, including PINK1 and Parkin, although there may be off-target effects (Mansour and El-Khatib, 2023).